Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
Better Growth Stock: Abbott vs. AbbVie
05:00am, Tuesday, 16'th Jan 2024
AbbVie launched about a decade ago as Abbott's spinoff of its pharmaceuticals business. Both companies have since lifted earnings into the triple digits.
The 7 Highest Yielding 2024 Dividend Kings To Buy and Hold Forever
09:47am, Sunday, 14'th Jan 2024
Altria owns over 10% of Anheuser-Busch InBev (NYSE: BUD), the world's largest brewer.
Here's the Average Amount Investors Have in Stocks by Age 40 and Which Stocks I Recommend Today
09:10am, Sunday, 14'th Jan 2024
Americans are increasingly interested in investing -- a great thing! It's important to set goals, and seeing these benchmarks can help.
How To Invest $1 Million In Retirement For Life-Long Income
09:00am, Saturday, 13'th Jan 2024
We outline an Income Strategy for creating a self-sufficient portfolio for retirees and income-focused investors with $1 million to generate a life-long income stream. We explain the benefits of gener
Final Trades: Abbvie, Stryker, Crown Castle, Marathon Petroleum
01:35pm, Friday, 12'th Jan 2024
Jim Lebenthal, chief equity strategist at Cerity Partners, Jenny Harrington, Gilman Hill Asset Management CEO, Joe Terranova, senior managing director at Virtus Investment Partners, and Brenda Vingiel
2 Ultrareliable Dividend Stocks to Buy in 2024 and Hold for at Least a Decade
05:39am, Thursday, 11'th Jan 2024
After underperforming the broad market over the past year, shares of Medtronic offer a 3.4% dividend yield. AbbVie shares offer a juicy 3.8% dividend yield even though the payout has grown 287% over t
3 Dividend Aristocrats Signal Buy In January With 7 To Watch
02:05pm, Wednesday, 10'th Jan 2024
"Dividend Aristocrats. in the S&P 500 Index… have raised their annual payouts every year for at least 25 consecutive years."--Kiplinger.com/Investing.
AbbVie Inc. (ABBV) J.P. Morgan 42nd Annual Healthcare Conference
01:48pm, Wednesday, 10'th Jan 2024
AbbVie Inc. (ABBV) J.P. Morgan 42nd Annual Healthcare Conference
AbbVie expects Botox market share to stay strong despite newer rivals
11:43am, Wednesday, 10'th Jan 2024
AbbVie expects its share of Botox in the aesthetics market to remain strong in the fourth quarter, despite recent launches of newer, longer-acting products by rival companies, the company's executive
My Dividend Stock Portfolio: New December Dividend Record - 98 Holdings With 18 Buys
08:20am, Wednesday, 10'th Jan 2024
The S&P500 delivered a strong year-end rally, gaining 4.5% in December and 26.3% for the year.
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
07:33pm, Tuesday, 09'th Jan 2024
AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
AbbVie (ABBV) Ascends While Market Falls: Some Facts to Note
06:47pm, Tuesday, 09'th Jan 2024
The latest trading day saw AbbVie (ABBV) settling at $162.31, representing a +0.55% change from its previous close.
3 Simple Tricks That Every Investor Should Use (but Most Don't)
10:15am, Tuesday, 09'th Jan 2024
There's no rule that mandates betting on only one company in a sector. It's valuable to learn about the top people involved in a business.
How To Build A Dividend Growth Portfolio As A 'Young Investor' With $100,000
03:34pm, Monday, 08'th Jan 2024
How To Build A Dividend Growth Portfolio As A 'Young Investor' With $100,000
AbbVie (ABBV) Now Trades Above Golden Cross: Time to Buy?
11:18am, Monday, 08'th Jan 2024
AbbVie Inc. (ABBV) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, ABBV's 50-day simple moving average crossed above its 200-
